Healthleap, a health tech startup that uses AI to spot hospital patients who may have undiagnosed illnesses, has raised $38 million. TechCrunch first reported the funding on October 7, 2026.
The money came in two rounds. Sequoia Capital and First Round Capital co-led an $8 million seed round, and Hummingbird Ventures led a $30 million Series A. The company did not share its valuation.
Siblings Jemima and Josiah Meyer founded Healthleap in South Africa in 2022. The company first sold a clinical nutrition tool that Jemima had built for dietitians.
It later shifted to a broader platform. The goal is to find hospital patients who may have conditions such as malnutrition or delirium that often go unnoticed early, said CEO and co-founder Josiah Meyer.
Meyer said a patient's chart holds two types of data. Lab results, weights, and vital signs are stored in set fields, but many warning signs appear in clinicians' written notes.
Those notes may mention poor appetite, recent weight loss, muscle loss, or trouble swallowing. Healthleap uses language models to pull these details out of the text.
How the Platform Works
The software connects to a hospital's electronic health record system. Each night, it reviews every adult inpatient's record, including labs, vitals, medications, diet orders, diagnoses, and clinical notes.
Each morning, it adds a risk score to the care team's existing workflow. A dashboard shows more details on each patient's trends.
The company says its software does not diagnose patients. It only flags cases that may need a closer review by staff.
The platform now screens for malnutrition and delirium in more than 50 hospitals. Healthleap has also built tools for aspiration pneumonia, pressure ulcers, and readmission risk for congestive heart failure, which are still going through clinical validation.
Malnutrition was a natural starting point. Research suggests 20% to 50% of hospital inpatients are malnourished, and studies have linked it to longer stays, slower wound healing, infections, and higher death rates.
Customers and Revenue Growth
Healthleap grew from three hospital partners to more than 50 in the past year. Customers include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare.
Meyer said revenue grew more than 10 times over the same period. He did not give exact figures.
The company sells three-year contracts priced by a hospital's licensed bed count. It also uses an outcome-based model and promises in its contracts to deliver several times the contract price in measurable returns.
Meyer said every customer so far has seen at least a 5x return, with some above 20x on an annual basis. At the Hospital of the University of Pennsylvania, the company says its malnutrition program produced $23.8 million in yearly financial impact.
That figure includes $6.3 million from extra reimbursement and $17.5 million from shorter hospital stays.
Healthleap plans to use the new funding for engineering, product, sales, and customer support. The company aims to cover more than 40 major health conditions and expand into outpatient and home care.
